FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information FDA ...
Belite Bio started rolling submission of a New Drug Application to the Food and Drug Administration for its treatment of a rare retinal disorder.
DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its ...
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
A Phase 3 trial found daraxonrasib nearly doubled survival in advanced pancreatic cancer, offering new hope ahead of FDA ...
Belite expects to complete the new drug application submission in the second quarter of 2026Rolling submission initiated ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence (“AI”) to develop transformative medicines ...
The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results